Le produit a bien été ajouté au panier.

discount label
H-SIIGFEKL-OH
Vue en 3D

Biosynth logo

H-SIIGFEKL-OH

Ref. 3D-PP44279

1mg
202,00 €
10mg
234,00 €
100mg
412,00 €
Livraison estimée en/au États-Unis, le vendredi 27 décembre 2024

Informations sur le produit

Nom :
H-SIIGFEKL-OH
Synonymes :
  • NH2-Ser-Ile-Ile-Gly-Phe-Glu-Lys-Leu-OH
Description :

Peptide H-SIIGFEKL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SIIGFEKL-OH include the following: Mini-intronic plasmid vaccination elicits tolerant LAG3+ CD8+ T cells and inferior antitumor responses VT Colluru , CD Zahm , DG McNeel - Oncoimmunology, 2016 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/2162402X.2016.1223002 Suboptimal T-cell receptor signaling compromises protein translation, ribosome biogenesis, and proliferation of mouse CD8 T cells TCJ Tan , J Knight , T Sbarrato - Proceedings of the , 2017 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1700939114 Interferon-γ and interleukin-4 reciprocally regulate CD8 expression in CD8+ T cells SH Apte , A Baz, P Groves, A Kelso - Proceedings of the , 2008 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0809549105 The tyrosine phosphatase PTPN22 discriminates weak self peptides from strong agonist TCR signals RJ Salmond , RJ Brownlie, VL Morrison - Nature , 2014 - nature.comhttps://www.nature.com/articles/ni.2958 Mechanistic target of rapamycin complex 1/S6 kinase 1 signals influence T cell activation independently of ribosomal protein S6 phosphorylation RJ Salmond , RJ Brownlie, O Meyuhas - The Journal of , 2015 - journals.aai.orghttps://journals.aai.org/jimmunol/article/195/10/4615/104772 Alteration of Cell Surface Sialylation RAIN CD - J Immunol, 2004 - academia.eduhttps://www.academia.edu/download/47694451/275.full.pdf Altered peptide ligands induce delayed CD8-T cell receptor interaction-a role for CD8 in distinguishing antigen quality PP Yachi, J Ampudia, T Zal , NRJ Gascoigne - Immunity, 2006 - cell.comhttps://www.cell.com/immunity/pdf/S1074-7613(06)00318-9.pdf Cytotoxic immunological synapses do not restrict the action of interferon-γ to antigenic target cells NSR Sanderson, M Puntel - Proceedings of the , 2012 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1116058109 The strength of T cell receptor signal controls the polarization of cytotoxic machinery to the immunological synapse MR Jenkins , A Tsun , JC Stinchcombe, GM Griffiths - Immunity, 2009 - cell.comhttps://www.cell.com/immunity/pdf/S1074-7613(09)00412-9.pdf IL-12 enhances CTL synapse formation and induces self-reactivity MA Markiewicz , EL Wise, ZS Buchwald - The Journal of , 2009 - journals.aai.orghttps://journals.aai.org/jimmunol/article/182/3/1351/83625 The half-life of the T-cell receptor/peptide-major histocompatibility complex interaction can modulate T-cell activation in response to bacterial challenge LJ Carre , SM Bueno , P Bull, SG Nathenson - , 2007 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2567.2007.02561.x Targeted calcium influx boosts cytotoxic T lymphocyte function in the tumour microenvironment KD Kim, S Bae , T Capece, H Nedelkovska - Nature , 2017 - nature.comhttps://www.nature.com/articles/ncomms15365 Stored Fas ligand, a mediator of rapid CTL-mediated killing, has a lower threshold for response than degranulation or newly synthesized Fas ligand JS He, DE Gong, HL Ostergaard - The journal of immunology, 2010 - journals.aai.orghttps://journals.aai.org/jimmunol/article/184/2/555/111850 JNK2 negatively regulates CD8+ T cell effector function and anti-tumor immune response J Tao, Y Gao, MO Li , W He, L Chen - European journal of , 2007 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200636726 Contractile actomyosin arcs promote the activation of primary mouse T cells in a ligand-dependent manner J Hong , S Murugesan, E Betzig, JA Hammer - PLoS One, 2017 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0183174 Cbl-b mitigates the responsiveness of naive CD8+ T cells that experience extensive tonic T cell receptor signaling J Eggert, WM Zinzow-Kramer , Y Hu , EM Kolawole - Science , 2024 - science.orghttps://www.science.org/doi/abs/10.1126/scisignal.adh0439 CD69 does not affect the extent of T cell priming E Alari-Pahissa, L Notario, E Lorente , J Vega-Ramos - PLoS , 2012 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0048593 LPA5 is an inhibitory receptor that suppresses CD8 T-cell cytotoxic function via disruption of early TCR signaling D Mathew , KN Kremer, P Strauch, G Tigyi - Frontiers in , 2019 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.01159 Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8+ T Cells CD Zahm , VT Colluru , DG McNeel - Cancer immunology research, 2017 - AACRhttps://aacrjournals.org/cancerimmunolres/article-abstract/5/8/630/468807 Alteration of cell surface sialylation regulates antigen-induced naive CD8+ T cell responses BP Pappu, PA Shrikant - The Journal of Immunology, 2004 - journals.aai.orghttps://journals.aai.org/jimmunol/article/173/1/275/72999 ESCRT-mediated membrane repair protects tumor-derived cells against T cell attack AT Ritter , G Shtengel , CS Xu , A Weigel , DP Hoffman - Science, 2022 - science.orghttps://www.science.org/doi/abs/10.1126/science.abl3855 CD3 aptamers promote expansion and persistence of tumor-reactive T cells for adoptive T cell therapy in cancer AP Menon, H Villanueva, D Meraviglia-Crivelli - Therapy-Nucleic Acids, 2024 - cell.comhttps://www.cell.com/molecular-therapy-family/nucleic-acids/fulltext/S2162-2531(24)00085-4 Alkylating chemotherapy may exert a uniquely deleterious effect upon neo-antigen-targeting anticancer vaccination AJ Litterman , AZ Dudek , DA Largaespada - Oncoimmunology, 2013 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.4161/onci.26294 Affinity thresholds for naive CD8+ CTL activation by peptides and engineered influenza A viruses AE Denton , R Wesselingh , S Gras - The Journal of , 2011 - journals.aai.orghttps://journals.aai.org/jimmunol/article/187/11/5733/85366 Hyperglycaemia does not affect antigen-specific activation and cytolytic killing by CD8+ T cells in vivo A Recino, K Barkan, FS Wong , G Ladds - Bioscience , 2017 - portlandpress.comhttps://portlandpress.com/bioscirep/article-abstract/37/4/BSR20171079/57449 N-hydroxy-amide analogues of MHC-class I peptide ligands with nanomolar binding affinities A Bianco , C Zabel, P Walden - of the European Peptide , 1998 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1099-1387(199812)4:8%3C471::AID-PSC166%3E3.0.CO;2-8

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP44279 H-SIIGFEKL-OH

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".